Onjisaponin A is researched for its multifaceted biological activities, particularly its anti-inflammatory and immunomodulatory effects, which may support treatments for chronic inflammatory conditions such as rheumatoid arthritis or atopic dermatitis.

It demonstrates anti-viral properties, especially against hepatitis-causing viruses, suggesting potential as a component in novel antiviral medications. Studies also indicate anti-cancer potential by inhibiting growth in certain cancer cells, including liver and lung cancer, paving the way for lead compounds in oncology.

Additionally, it promotes wound healing and enhances skin barrier function, positioning it as a candidate for dermatological applications. It features in traditional medicine formulations for respiratory and infectious diseases and is investigated for adjuvant roles in vaccine development due to its immune-stimulating capabilities.

Onjisaponin A may also be incorporated into health supplements to bolster immunity. Further clinical studies are required to validate its safety and efficacy in humans.